SlideShare a Scribd company logo
1 of 65
Presented By- Ruchi Saharan
S.Y M.Pharm( Pharmacognosy),GCP
Department of Phytochemistry
NRPL
Isolation & characterisation
of Phytoconstituents from
Withania somnifera Root
Introduction
• Withania somnifera has been an important herb in the ayurvedic & indigenous medicinal
system for centuries in India.[1]
• It is described as an herbal tonic & health food in Vedas and considered as ‘Indian Ginseng’ in
traditional Indian system of medicine.[2]
• Medicinally important plant known for variety of pharmacologically important withanolides
& their glycosides.
• Ashwagandha plant is especially attractive for studying the enzymes involved in steriodal
transformation like glycosylation because it is a rich source for variety of glycosylated
steroidal lactones called withanosides present in roots & leaves.[3]
• Withanosides mainly comprises of withanolides with one or more glucose units attached to C-
3 or C-27 position.
2
Plant profile[4]
Withania somnifera
Botanical Name: Withania somnifera (L) Dunal
Family : Solanaceae
Synonyms(s) : Physalis flexuosa L
3
Taxonomical classification[4]
Kingdom : Plantae
Division : Angiosperma
Class : Dicotyledoneae
Order :Tubiflorae
Family : Solanaceae
Genus :Withania
4
Macroscopic[5],[6]
• The sout fleshy roots when dry are cylindrical, gradually tapering down, straight,
unbranched, 10-17.5cm long & 6-12mm in diameter.
• The main roots bear fibre-like secondary roots.
• The outer surface of the roots is brownish white and interior in creamy white when
broken.
• They have a short and uneven fracture, a strong odour and mucilaginous bitter &
acrid taste.
5
Microscopic [5],[6]
• The young roots has a single layered epidermis followed by parenchymatous cortex
of 4-5 layers of cells, the endodermis being conspicuous by the presence of
casparian stipes.
• The cork cambium arises in the outermost layer of the cortex.
• The endodermis persists even after the secondary growth has been taken place.
6
Geographical Distribution[7]
• Withania somnifera is widely distributed around the world from Southern
Mediterranean regions to the canary island and from south to East Africa, from
Palestine to north India.
• India the plant can be seen growing wild in the North Western regions
extending to the mountains regions of Punjab, Himachal Pradesh and Jammu
up to an altitude of 1,500m.
7
Chemical constituents [8,9,10]
8
SL.No Category Phytoconstituents
1 Alkaloids Withanine,Withaninine, Somniferine,Tropeltigloate, Somniferinine,
somninine,Visamine,Withasomine.
2 Salts Cuscohygrine,Anahygrine,Tropine,Pseudotropine,Anaferine.
3 Steriodal lactones Withaferin –A,Withanone,WS-1, Withanolide-A,B,E,F,G,H,I,J,K,L,M, 12-
deoxy Withastramonolide, Withanoside IV, Withanoside V.
4 N- containing lactones Withanol, Somnisol,Somnitol.
5 Steroids Cholesterol,β-sitosterol,
stigmasterol,Diosgenin,stigmastadien,sitoinosidesVII, sitoinosides VIII,
Sitoinosides IX, sitoinosides X.
6 Flavonoids Kaempferol,Quercetin.
WITHANOLIDES [8]
• These are group of naturally occuring steroids built on an ergostane skeleton in
which C-22 & C-26 are appropriably oxidised to form a α- lactone ring, occuring
almost exclusively in the solanaceae family.
• Two new and seven known withanolides along with β-sitosterol, stigmasterol, β-
sitosterol glucoside, stigmasterol glucoside, α + β glucose were isolated from the
roots of Withania somnifera.
• Among the known compounds, Viscosa lactone B, stigmasterol, stigmasterol
glucoside and α + β glucose are being reported from the roots of W. somnifera for
the first time.
• One of the new compounds contained the rare 16β-acetoxy-17(20)-ene the other
contained unusual 6α-hydroxy-5,7α-epoxy functional groups in the withasteroid
skeleton.
9
Structures
O
CH3
OH
CH3
H3C
OH
CH3
O
O
WITHAFERIN A
O
O
CH3
CH3
CH3
OH
H3C
OH O
OH
WITHANOLIDE A
CH3
OH
CH3
CH3
OH O
H3C
O
O
WITHANOLIDE B
HO
O
O
H
H
O
O
OH
H
H
H
12-deoxy
WITHASTRAMONOLIDE
10
OH
HO
OH
HO
O
O
OHHO
OH
O
O
H
H
H
H
H
OH
H
H
WITHANOSIDE V
O
OH
HO
OH
HO
O
O
OHHO
OH
O
O
H
H
OH
H
H
H
H
OH
O
WITHANOSIDE IV
11
Traditional and medicinal uses[11]
Roots of the plant withania somnifera reportedly exhibits:
• Anti-inflammatory
• Antitumor
• Antistress
• Antioxidant
• Immunomodulatory
• Haematopoietic
• Aphrodisiac
• Dyspepsia
• Sedative
Carminative
• Diuretic
• Bactericide 12
Objectives
• To isolate Root specific marker which are absent in leaves /aerial part.
• Isolation of Withanolide-B & other Withanolides from enriched fractions.
• Isolation of new marker apart from our regular compounds.
• Publication on Root specific markers & others.
13
Previous work done
• Yogendra et.al-PLT-129
• The compound isolated was a derivative of withanolide which is having conjugated
diene ring system. The proposed structure was
• The compound isolated is specific to roots only (Confirmed by HPLC).
14
O
O
O
H3C
CH3
CH3
CH3
CH3
OH
Partitioning of Withania somnifera methanolic extract – Pilot scale
15
Present Work
16
Withania somnifera
methanolic extract 3Kg
Ethyl acetate layer
35.33%
(1060g)
Butanol layer
37.0%
(1110g)
Water layer
20.67%
(620.5g)
Mixed layer
2.0%
(60.1g)
Total quantity= 2.85Kg
HPLC analysis was carried out on all the above fractions
Partition with 45L of solvents
Partition overlay
17
18
Partition Quantification
Sl.
No.
Sample Withanoside
IV
Withanoside
V
Withaferin
A
Withastra
monolide
Withanolide
A
Withanolide
B
Total Assay of
WSR-03
1 Initial ME
ext
0.42 0.45 0.26 0.26 0.41 0.12 2.42 0.016
2 EA layer
0.43 0.31 3.04 3.04 2.94 0.86 15.23 0.154
3 Butanol
layer 4.69 3.73 1.19 1.19 1.80 0.36 15.62 0.025
4 Water layer
0.41 0.68 0.17 0.17 0.27 0.02 2.05 ND
19
Column chromatography on Ethyl acetate fraction... Column -1
1Kg of Ethyl acetate fraction + 2Kg of silica (120- 200) mixed adsorbed dried it.
Column charged with silica (60-120) 3Kg(1:3) Using wet packing.
sample is packed & 100% PE was elulated to deffat drug
Subsequently the mobile phase was (PE : EA) in the ratio of
90 : 10, 80 :20, 70 : 30, 60 : 40.......
20
F1
80:20
P/E
F2(1)
70:30
P/E
F2(2)
70:30
P/E
F3
60:40
P/E
F4
50:50
P/E
F5
40:60
P/E
F6
30:70
P/E
F7
20:80
P/E
F8
10:90
P/E
F9
100
EA
F10
90:10
E/M
F11
80:20
E/M
F 12
60:40
E/M
F13
40:60
E/M
F 14
20:80
E/M
F15
100
M
F16
50:50
M/H2O
67.5 g 49.5g 72.0 g 43.0 g 29.5 g 25.5 g 30.0 g 49.5 g 55.0 g 54.5 g 56.0 g 78.0 g 135.0 g 44.5 g 79.5 g 24.5 g 14.0 g
1 Kg of Withania
Ethyl acetate partition layer
• P/E= PE:EtOAc
• E/M = EtOAc: MeOH
5L of solvent is run
21
Total quantity obtained= 907g
HPLC analysis was carried out for the above fractions
WSR-03 Overlay
22
23
Withanolides enriched fractions
24
Quantification Result-Column 1
Sample Wt. Withanoside IV Withanoside V Withaferin A Withastramonolide Withanolide A Withanolide B Total WSR-03 WSR-01
EA layer 1060g 0.21 0.31 6.88 1.83 2.08 0.63 11.94 0.14 0.24
F-5 29.5g 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 ND
F-6 25.5g 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.63 0.19
F-7 30.0g
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.17 0.53
F-8 49.5g
0.37 0.00 1.71 0.13 2.54 1.16 5.92 0.51 0.79
F-9 55.0g 0.44 0.06 3.29 0.24 2.32 1.14 7.49 0.43 1.01
F-10 54.5g
0.63 0.17 10.58 1.20 7.05 2.17 21.80 0.17 0.96
F-11 56.0g
ND ND 18.65 4.13 4.69 1.33 28.81 0.08 0.43
F-12 78.0g
0.39 ND 17.79 4.77 4.19 1.35 28.49 0.10 0.42
F-13 135.0g ND ND 13.54 4.72 2.69 0.43 21.38 0.00 0.00
F-14 44.5g
2.21 3.78 2.71 2.23 2.00 0.42 13.35 0.00 0.00
F-15 79.5g
2.70 2.62 1.94 1.82 1.96 0.46 11.50 0.00 0.00
F-16 24.5g 1.43 1.10 1.08 1.36 1.85 0.47 7.30 0.00 0.00
F-17 14.0g
1.19 1.00 3.15 0.91 0.68 0.12 7.05 0.00 0.00
25
Selected for
COLUMN -2
Future Plan of work
• Fractions-10,11,12,13 from Column -1 were selected for next Silica column to
isolate Withanolide B & to generate enriched fractions for WSR-03, 01 & other
withanolides.
26
Column chromarography-2
27
300g of fractions -10,11,12,13 of Column-1
C2F1
100%PE
C2F2
90:10
PE:EA
C2F3
80:20
PE:EA
C2F4
70:30
PE:EA
C2F5
60:40
PE:EA
C2F6
50:50
PE:EA
C2F7
40:60
PE:EA
C2F8
30:70
PE:EA
C2F9
20:80
PE:EA
C2F10
10:90
PE:EA
C2F11
100%EA
C2F12
90:10
EA:MeOH
C2F13
70:30
EA:MeOH
C2F14
50:50
EA:MeOH
100%
MeOH
0.3g - 2.5g 3.3g 9.6g 6.3g 10.3g 22.2g 14.2g 14.2g 57.0g 113.0g 40.0g 7.4g 1.8g
Column-3 Column-4
Total Quantity Obtained=292.5g
Column-5
Targeted WSR-03
HPLC Analysis
(WSR-03,01 Quantification)
28
WSR 03 2.04/25 RT
28.17 ASSAY ASSAY
sample Weight WSR 03 WSR 01
Control 0.08 0.36
F4 3.3g 0 0.00
F5 9.6g 1.34 0.00
F6 6.3g 1.22 0.00
F7 10.3g 0.27 1.41
F8 22.2g 0.00 3.29
F9 14.2g 0.15 0.80
F10 14.2g 0.05 0.51
F11 57.0g 0.01 0.09
F12 113.0g 0.00 0.05
COLUMN-3
COLUMN-4
Withanolide Quantification
29
Batch No Weight Withanoside
V
Withaferin A Withastramonolid
e
Withanolide A Withanolide B
Control 17.03 5.59 3.92 1.13
F4 3.3g 0.00 0.00 0.00 0.00 0.00
F5 9.6g 0.00 0.00 0.00 0.00 0.00
F6 6.3g 0.00 0.00 0.00 1.56 0.00
F7 0.3g 0.00 0.00 0.00 1.39 1.98
F8 22.2g 0.00 0.00 0.00 1.69 3.60
F9 14.2g 0.00 0.00 0.00 11.45 2.12
F10 14.2g 0.00 5.55 0.00 10.03 2.68
F11 57.0g 0.00 23.24 8.01 4.64 1.12
F12 113.0g 0.00 17.57 5.21 2.53 0.44
F13 40.0g 0.00 4.21 2.45 1.87 0.18
F14 7.4g 1.88 1.70 1.11 0.70 0.08
F15 1.8g 1.04 0.37 0.30 0.11
COLUMN-3
COLUMN-4
Withanolide Overlay
30
31
WSR-03 OVERLAY
32
Column Chromatography-3
33
C3F6 C3F7(1)
PPT
C3F7(2) C3F7(3) C3F7(3)
MLR
C3F7(1),(2)
MLR
C3F8 C3F9 C3F10 C3F11 C3F11-
MLR
C3F12 C3F13,14,
15,16
EA:CHCl3
10:90
EA:CHCl3
20:80
EA:CHCl3
20:80
EA:CHCl3
20:80
EA:CHCl3
20:80
EA:CHCl3
20:80
EA:CHCl
3
30:70
EA:CHCl3
40:60
EA:CHCl3
30:70
EA 100% EA 100% MeOH:EA
10:90
MeOH:EA
25%,50%
100%MeOH,50
% H2O
0.3g
paste
powder 87.0mg
Light
Green
powder
147.47mg
light
Green
powder
0.2g
paste
2.1g
paste
0.6g
paste
3.6g
paste
4.3g
paste
683.0mg
White
powder
2.9g
Brown
paste
4.8g
paste
2.4g
Brown
paste
C2F8
Qty charged (21g) - Wet-packing
Total quantity obtained= 19.5gm
Isolated
Withanolide –B New peak
RT-19.954
WSR-01 Enriched
+
Withanolide-B
34
WSR 03 2.04/25 RT
28.13 ASSAY ASSAY
sample Weight WSR 03 WSR 01
C-3 Control - 0.00 2.96
C3-F6 0.3g
C3-F7(1&2)MLR 2.1g 0 14.01
C3-F7(2) 87.0mg 0 6.97
C3-F7(3) 147.47g 0 3.61
C3-F7(3)MLR 0.2g 0.48
C3F8 0.6g 1.83 0.60
C3F9 3.6g 0.51
C3F10 4.3g 1.23 0.20
C3F11 683.0mg 0.71
C3F11MLR 2.9g 0.66
C3F12 4.8g 0.20 0.19
C3F13,14,15,16 MIX 2.4g 0.13
WSR-03,01 Quantification
WSR-01 Enriched
fractions
WSR-03 Enriched
fractions
Withanolide Quantification
35
Sr.no Batch No
Weight
Withanolide A Withanolide B
-
1 C-3 Control 1.65 3.06
2 C3-F6 0.3g 3.90 1.19
3 C3-F7(1&2)MLR 2.1g 8.71
4 C3-F7(2) 87.0mg 61.31
5 C3-F7(3) 147.47g 56.67
6 C3-F7(3)MLR 0.2g 0.51 4.83
7 C3F8 0.6g 0.68
8 C3F9 3.6g 3.53
9 C3F10 4.3g 0.19 0.00
10 C3F11 683.0mg
11 C3F11MLR 2.9g
12 C3F12 4.8g
13 C3F13,14,15,16 MIX 2.4g
-
Column Chromatography-4
36
C4F6
(2),(3)
C4F7
(1),(2)
PPT
C4F7
(1),(2)
MLR
C4F8
C4F8
MLR
C4F9
(1),(2)
C4F9
MLR
C4F10
PPT
C4F10
MLR
C4F10
(2)
C4F11 (1) C4F11
C4F12
PPT
C4F12
MLR
C4F13
C4F
14,15
MIX
EA:CHCl3
EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3
100% EA 100&EA MeOH: EA
MeOH: EA
MeOH:
EA
MeOH: EA
25,50,100%
MeOH,
50%H20
1.4g
paste
0.9g
paste
439.80
mg
powder
4.6g
paste
1.28g
powder
2.0g
Green
powder
3.24g
powder
3.6g
paste
4.2g
powder
0.3g
Greenish
powder
9.8g
paste
342mg
powder
1.7g
paste
3.4g
paste
418.0mg
Brown
powder
Withanolide –B
Islolated
C2F9 & C2F10
Qty charged- 27g (wet-packing)
Total quantity obtained= 25.5g
Withanolide –A Enriched
fraction
Withanolide-A & Withastramonolide
Enriched fractionWithanolide-A & B
Enriched fraction
Withanoside IV Enriched
New peak
RT- 23.642
Withaferin-A Enriched
• From fractions
C3F7(1) & C4F7 (1,2) 190.0mg Withanolide –B isolated (> 95%).
37
Combined
Withanolide Quantification
38
Sr.no Batch No Weight Withanoside IV Withanoside V Withaferin A
Withastramonoli
de
Withanolide
A
Withanolide
B
1 C-4 Control - 1.91 0.62 3.46 6.00 8.28 1.98
2 C4F6(2&3) 1.4g 0.00 0.00 0.00 0.00 0.23 0.00
3 C4F7(1&2MLR) 0.9g 0.00 0.00 0.00 0.00 0.00 4.53
4 C4F8 439.80 0.00 0.00 0.00 0.00 13.80 24.69
5 C4F8MLR 4.6g 0.00 0.00 0.00 0.00 2.50 6.11
6 C4F9(1&2) 1.28g 0.00 0.00 0.00 0.00 49.64 8.47
7 C4F9MLR 2.0g 0.00 0.00 0.00 3.84 18.91 5.61
8 C4F10(2) 3.24g 7.53 0.00 0.00 11.88 9.00 0.00
9 C4F10MLR 3.6g 34.37 0.00 0.00 3.07 0.59 0.00
10 C4F10PPT 4.2g 0.00 0.00 0.00 26.12 34.75 0.00
11 C4F11(1) 0.3g 0.00 2.66 7.99 4.39 0.00 0.00
12 C4F11 9.8g 1.80 5.21 0.00 0.00 0.00
13 C4F12MLR 342.0mg 0.00 0.00 0.00 0.00 0.00
14 C4F12PPT 1.7g 0.00 0.00 0.00 0.00
15 C4F14&15 MIX 418.0mg 0.00 0.00 0.00 0.00 0.00 0.00
WSR-03 Quantification
39
Sr.No sample weight WSR 03 WSR 01
1 C-4 Control - 0.07 0.53
2 C4F6(2&3) 1.4g 0
3 C4F7(1&2MLR) 0.9g 1.6 0.00
4 C4F8 439.80 0.29 0.78
5 C4F8MLR 4.6g 1.46 4.76
6 C4F9(1&2) 1.28g 0.14 0.29
7 C4F9MLR 2.0g 0.87 4.22
8 C4F10(2) 3.24g
9 C4F10MLR 3.6g
10 C4F10PPT 4.2g
11 C4F11(1) 0.3g
12 C4F11 9.8g
13 C4F12MLR 342.0mg
14 C4F12PPT 1.7g
15 C4F14&15 MIX 418.0mg
Column Chromatography-6
40
(C6F1-C6F5)
PE:CHCl3
75:25
50:50
25:75& 100 %
CHCl3
C6F6 (1) C6F6 (2) C6F6 (3) C6F7 (1) C6F7 (2) C6F8(1) C6F8 (2) C6F8 (3) C6F9 (1) C6F9 (2) C6F10 (1) C6F11
EA:CHCl3
20:80
EA:CHCl3
20:80
EA:CHCl3
20:80
EA:CHCl3
40:60
EA:CHCl3
40:60
EA:CHCl3
60:40
EA:CHCl3
60:40
EA:CHCl3
60:40
EA:CHCl3
80:20
EA:CHCl3
80:20
100%
EA
MeOH: EA
20:80 &
100%
MeOH
9.0g
powder
9.0g
powder
3.5g
powder
5.2g
powder
10.0g
powder
7.6g
powder
4.0g
powder
2.3g
powder
2.6g
powder
1.9g
powder
1.3g
powder
1.9g
Brown
powder
C2F11
Qty charged: 56g (wet-packing)
Total quantity obtained= 54.3g
New peak
RT-12.639
New peak
RT-15.939 New peak
RT-17.494
Column-7
Target –Peak RT-15.9
Withaferin –A
Side peak
Withanolide Quantification (C-6)
41
Sr.No Batch No Weight Withaferin A Withastramonolide Withanolide A Withanolide B
1 C6-Control-13 - 18.15 6.71 4.23 0.96
2 C6F6-1 9.0g 16.50 9.17 9.18 4.07
3 C6F6-2 9.0g 17.29 7.66 6.26 1.83
4 C6F6-3 3.5g 17.30 7.42 5.35 0.35
5 C6F7-1 5.2g 18.28 6.44 3.57 0.00
6 C6F7-2 10.0g 17.69 5.94 2.38 0.00
7 C6F8-1 7.6g 22.40 5.68 0.42 0.00
8 C6F8-2 4.0g 15.15 4.66 0.00 0.00
9 C6F8-3 2.3g 9.83 2.59 0.00 0.00
10 C6F9-1 2.6g 6.67 1.87 0.00 0.00
11 C6F9-2 1.9g 9.35 1.09 0.00 0.00
12 C6F10-1 1.3g 3.36 0.55 0.00 0.00
13 C6F11-1 1.9g 4.69 0.00 0.00 0.00
C-7
42
Withanolide overlay
OVERLAY OF PEAK (RT-17)
43
Column Chromatography-7
44
C7F1 C7F2 C75F3 C7F4(1) C7F5(1) C7F5(2) C7F5(3) C7F6(1) C7F6(2) C7F6(3) C7F6(4) C7F6(5) C7F7(1)
100%
PE
5%
Ac: PE
10%
Ac: PE
15%
Ac: PE
20%
Ac: PE
20%
Ac: PE
20%
Ac: PE
25%
Ac: PE
25%
Ac: PE
25%
Ac: PE
25%
Ac: PE
25%
Ac: PE
30%
Ac: PE
- - -
11.0mg
powder
2.7g
powder
1.8g
powder
0.8g
powder
20.0mg
powder
5.0mg
powder
3.0mg
powder
2.0mg
powder
3.0mg
powder
5.0mg
powder
C6F8(1)
Qty:7g charged ( wet-packing)
Ac : Acetone
PE: Petroleum Ether
Total Qty obtained= 5.3g
Enriched with peak
RT-15
Isolated Withaferin-A
(1.0g)
By crystaliazation
OVERLAY
45
Quantification
46
Sr.No Batch No Weight Withanoside -IV Withanoside -V Withaferin - A Withastramonolide
1 C7 CONTROL - 0 0 0.56 0.53
2 C7F4 11mg 0 0 41.29 24.51
3 C7F5(1) 2.7g 0 0 12.83 8.32
4 C7F5(2) 1.8g 0 0 68.25 2.179
5 C7F5(3) 0.8g 0 0 46.65 2.61
Enriched with
peak RT-15.15
Quantification (Peak RT-14.8 & 15.15)
47
RT 14.8 weight Assay
C7-Control - 23.29
C7F5(1)
C7F5(2) 1.8g 5.58
C7F5(3) 0.8g 24.75
RT 15.15 weight Assay
C7-Control - 10.43
C7F5(1)
C7F5(2) 1.8g 4.48
C7F5(3) 0.8g 7.75
Column Chromatography- 5
C5F1 C5F2 C5F3 C5F4(1) C5F4(2) C5F4(3) C5F4(4) C5F5(1) C5F5(2) C5F6 PPT C5F6 MLR C5F7 (1) C5F8
100%
PE
50%
CHCl3 : PE
75%
CHCl3 : PE
3%
EA:CHCl3
3%
EA:CHCl3
3%
EA:CHCl3
3%
EA:CHCl3
10%
EA:CHCl3
10%
EA:CHCl3
15%
EA:CHCl3
15%
EACHCl3
20%
EACHCl3
100%
MeOH
48
C2F6
Qty charged-6g (wet-packing)
Enriched with
WSR-03
WSR- 03 OVERLAY
49
WSR-03 Quantification
50
Sr.No Sample
Assay
WSR 03
1 Control 1.05
2 C5F4 (2) 4.63
3 C5F4( 3) 7.29
Column Chromatography- 8 (HP20 Diaion)
51
C1F7
Qty charged-30g
C8F4 C8F5 C8F6 C8F7 C8F8 C8F9 C8F10 C8F11 C8F12 C8F13 C8F14 C8F15
10+20%
Acetone:
H2O
30%
Acetone:
H2O
35%
Acetone:
H2O
35+40%
Acetone:
H2O
40%
Acetone:
H2O
(MLR)-1
40%
Acetone:
H2O
(MLR)-2
45%
Acetone:
H2O
(MLR)-1
45%
Acetone:
H2O
(MLR)-2
50%
Acetone:
H2O
60%
Acetone:
H2O
80%
Acetone:
H2O
100%
Acetone
- - - - - - 2.0g 1.0g 1.5g 1.5g 15.0g 7.5.0g
Enriched with WSR-03,01
52
Sr.no sample Wt
Assay
WSR 03
Assay
WSR 01
1 Control - 1.19 0.54
2 F10 2.0g 2.09 3.16
3 F11 1.0g 5.17 2.09
4 F12 1.5g 3.90 0.27
5 F13 0.17 0.00
Quantification Result
53
Column Chromatography-9 (HP 20 Diaion)
C9F1 C9F2 C9F3 C9F4 C9F5 C9F6 C9F7 C9F8
100%
H2 O
10%
Acetone: H2 O
20%
Acetone: H2 O
30%
Acetone: H2 O
40%
Acetone: H2 O
60%
Acetone: H2 O
80%
Acetone: H2 O
100%
Acetone
0.2 0.1g 0.2g 0.2g 2.1g 1.2g 6.1g 9.0g
C1F6
Qty charged-20.0g
Total Quantity obtained= 18.2 g
54
C10F3 C 10F4 C10F5
(PPT)
C10F6
(MLR)
C10F6
(PPT)
C10F6
(MLR)
C10F7 C10F8
30%
Acetone: H2 O
40%
Acetone: H2 O
50%
Acetone: H2 O
50%
Acetone: H2 O
60%
Acetone: H2 O
60%
Acetone: H2 O
80%
Acetone: H2 O
100%
Acetone
0.2g 10.0g 7.0g 5.0g 0.5g 5.0g 25.0g 20.0g
Column Chromatography-10 (HP 20 Diaion)
C1F6
Qty charged-80.0g
Total Quantity obtained= 72.7g
55
C11F2 C11F3 C11F4 C11F5 C11F6 C11F7 C11F8 C11F9 C11F10 C11F11 C11F12
10%
EA:CHCl3
20%
EA:CHCl3
30%
EA:CHCl3
40%
EA:CHCl3
60%
EA:CHCl3
80%
EA:CHCl3
100%
EA
10%
MeOH:EA
20%
MeOH:EA
40%
MeOH:EA
70%
MeOH:EA
+ 100%
MeOH
85.92mg 164.6mg 1.7g 2.9g 310.6mg 922.5mg 1.7g 13.5g 24.7 20.0g 2.2g
Column chromatography-11
C1F14
Qty charged-75.0g (Wet packing)
Isolated Withanolide-B Isolated Withanolide-A
New peak
RT-17.2
Withastramonolide
+
Withaferin –A enriched
Column-12
56
C12F6
PPT
C12F7
PPT
C12F8
PPT
C12F9
PPT
C12F10
PPT (1)
C12F10
PPT (2)
65%
EA:CHCl3
70%
EA:CHCl3
75%
EA:CHCl3
80%
EA:CHCl3
10%
MeOH
10%
MeOH
266.5mg 386.2mg 262.8mg 182.2mg 49.4mg 61.6mg
Column chromatography -12
C11F9 (13.0g) wet packing
57
Column chromatography-12
C11F9
Qty charged-13.0g (Wet packing)
58
59
60
61
62
Column chromatography-12
C11F9
Qty charged-13.0g (Wet packing)
References
1. Indian Herbal Pharmacopoeia A Joint Publication of Regional Research institute (Jammu Tawai) and
Indian Drug Manufacturer’s Association (Mumbai); 1999.
2. Owais M, Sharad KS, Shehbaz A, Saleemuddin M. Antibacterial efficacy of withania somnifera an
indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine. 2005;12:229-
235.
3. Bhaskara RM, Lokendra KS, Pankaj C, Rajender SS, Rakesh T. Purification & characterization of a
novel glucosyltransferase specific to 27- hydroxyl steriodal lactose from withania somnifera and its role
in stress responses Biochimica Biophysica Acta.2007; 1774: 1199-1207.
4. Withania somnifera Master Document; Natural Remedies Private Ltd.Bengaluru.
5. The Unani Pharmacopoeia of India. Part I, Vol. I, Depat. of AYUSH, Ministry of Health & Family
Welfare, Govt. of India, New Delhi (2007) 7-8.
6. Standardisation of Single Drugs of Unani Medicine. Part III, 1st ed. Central Council for Research in
Unani Medicine (CCRUM), New Delhi (2007) 9-14.
7. Shah CS and Qadri JS. Textbook of Pharmacognosy. 9th ed. BS Shah Prakashan, New Delhi (1993).
8. Singh S, Kumar S, withania somnifera: The Indian Ginseng, Ashwagandha. Central Institute of
Medical an Aromatic Plants, Lucknow, India; 1998
63
9. Wilk, S Orlowski, M wilk, Pearce. Novel in vitro and in vivo inhibitors of Prolyendo peptidase. Journal of
Neurochemistry life sci. 1983; 33: 2149- 2157.
10. Steroids-Chemical constituents of Withania somnifera Dunal through TLC & HPLC. Monika christian
et.al. IRJP.ISSN 2321-2845,2321,3299.
11. Mark E , Allan W, Nicholas, John PR. High presssure liquid chromatography of derivatives & microbial
metabolites of withaferin- A. J . Chrom. 1977; 137; 465-467.
12. Traditional And Medicinal Uses of Withania Somnifera. M. Umadevi1 et.al. The Pharma Innovation .
2012, vol.1 No.9 : 102-110
64
65

More Related Content

What's hot

Phytopharmaceuticals - By Dr.U.Srinivasa, Professor and Head, Srinivas coll...
 Phytopharmaceuticals -  By Dr.U.Srinivasa, Professor and Head, Srinivas coll... Phytopharmaceuticals -  By Dr.U.Srinivasa, Professor and Head, Srinivas coll...
Phytopharmaceuticals - By Dr.U.Srinivasa, Professor and Head, Srinivas coll...ummanabadsrinivas
 
Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)
Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)
Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)Devyani Joshi
 
Azadirachta indica (neem)
Azadirachta indica  (neem)Azadirachta indica  (neem)
Azadirachta indica (neem)imran khan
 
evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...
evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...
evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...PATHEPARAPU HANUMANTHA RAO
 
Vinca : Chemical constituents, commercial products and uses
Vinca : Chemical constituents, commercial products and usesVinca : Chemical constituents, commercial products and uses
Vinca : Chemical constituents, commercial products and usesSonia Singh
 
Introduction to Plant Biotechnology- Durgashree Diwakar
Introduction to Plant Biotechnology- Durgashree DiwakarIntroduction to Plant Biotechnology- Durgashree Diwakar
Introduction to Plant Biotechnology- Durgashree DiwakarDurgashree Diwakar
 
Plant sweetners by pooja
Plant sweetners by poojaPlant sweetners by pooja
Plant sweetners by poojaPOOJA KHANPARA
 
Black pepper, kalimircha Pipper nigrum Linn lysine derivatives , plant conta...
Black pepper, kalimircha Pipper nigrum Linn lysine derivatives  , plant conta...Black pepper, kalimircha Pipper nigrum Linn lysine derivatives  , plant conta...
Black pepper, kalimircha Pipper nigrum Linn lysine derivatives , plant conta...Pranjali Kesharwani
 
Recent Advances in Extraction
Recent Advances in ExtractionRecent Advances in Extraction
Recent Advances in ExtractionKaustav Dey
 

What's hot (20)

Fennel Cultivation
Fennel CultivationFennel Cultivation
Fennel Cultivation
 
Vinca alkaloids
Vinca alkaloidsVinca alkaloids
Vinca alkaloids
 
Phytopharmaceuticals - By Dr.U.Srinivasa, Professor and Head, Srinivas coll...
 Phytopharmaceuticals -  By Dr.U.Srinivasa, Professor and Head, Srinivas coll... Phytopharmaceuticals -  By Dr.U.Srinivasa, Professor and Head, Srinivas coll...
Phytopharmaceuticals - By Dr.U.Srinivasa, Professor and Head, Srinivas coll...
 
Eucalyptus oil
Eucalyptus oil Eucalyptus oil
Eucalyptus oil
 
Guggul
GuggulGuggul
Guggul
 
Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)
Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)
Pharmacognosy: Cinnamon (Cinnamomum zeylanicum)
 
Azadirachta indica (neem)
Azadirachta indica  (neem)Azadirachta indica  (neem)
Azadirachta indica (neem)
 
evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...
evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...
evaluation of phytochemical, anti-oxidant, anti-inflammatory, and cytotoxicit...
 
alovera-liliaceae
alovera-liliaceaealovera-liliaceae
alovera-liliaceae
 
Vinca : Chemical constituents, commercial products and uses
Vinca : Chemical constituents, commercial products and usesVinca : Chemical constituents, commercial products and uses
Vinca : Chemical constituents, commercial products and uses
 
Ginseng
GinsengGinseng
Ginseng
 
Introduction to Plant Biotechnology- Durgashree Diwakar
Introduction to Plant Biotechnology- Durgashree DiwakarIntroduction to Plant Biotechnology- Durgashree Diwakar
Introduction to Plant Biotechnology- Durgashree Diwakar
 
cinnamon
cinnamoncinnamon
cinnamon
 
Plant sweetners by pooja
Plant sweetners by poojaPlant sweetners by pooja
Plant sweetners by pooja
 
Pharmacognosy and phytochemistry ii (theory)
Pharmacognosy and phytochemistry ii (theory)Pharmacognosy and phytochemistry ii (theory)
Pharmacognosy and phytochemistry ii (theory)
 
Black pepper, kalimircha Pipper nigrum Linn lysine derivatives , plant conta...
Black pepper, kalimircha Pipper nigrum Linn lysine derivatives  , plant conta...Black pepper, kalimircha Pipper nigrum Linn lysine derivatives  , plant conta...
Black pepper, kalimircha Pipper nigrum Linn lysine derivatives , plant conta...
 
Andrographis paniculata
Andrographis paniculataAndrographis paniculata
Andrographis paniculata
 
Recent Advances in Extraction
Recent Advances in ExtractionRecent Advances in Extraction
Recent Advances in Extraction
 
Clove presentation
Clove presentationClove presentation
Clove presentation
 
HERBAL COSMETICS UNIT 2, PCG SEM 2.pptx
HERBAL COSMETICS UNIT 2, PCG SEM 2.pptxHERBAL COSMETICS UNIT 2, PCG SEM 2.pptx
HERBAL COSMETICS UNIT 2, PCG SEM 2.pptx
 

Similar to PPT-2 MODIFIED(1)

comparsion of anti-inflammatory activity of bauhina variegata
comparsion of anti-inflammatory activity of bauhina variegatacomparsion of anti-inflammatory activity of bauhina variegata
comparsion of anti-inflammatory activity of bauhina variegatakonatham teja kumar reddy
 
tooba shafi presentation.pptx
tooba shafi presentation.pptxtooba shafi presentation.pptx
tooba shafi presentation.pptxToobaNoor29
 
Sekar_Powerpoint Presentation UKM
Sekar_Powerpoint Presentation UKMSekar_Powerpoint Presentation UKM
Sekar_Powerpoint Presentation UKMSekar Galuh
 
nilab gul new presentation.pptx
nilab gul new presentation.pptxnilab gul new presentation.pptx
nilab gul new presentation.pptxSabaFaseeh
 
Flash chromatography guided fractionation and antibacterial activity studies ...
Flash chromatography guided fractionation and antibacterial activity studies ...Flash chromatography guided fractionation and antibacterial activity studies ...
Flash chromatography guided fractionation and antibacterial activity studies ...IOSR Journals
 
Phytochemical and Biological Evaluation of Cassia tora, L. Seeds
Phytochemical and Biological Evaluation of Cassia tora, L. SeedsPhytochemical and Biological Evaluation of Cassia tora, L. Seeds
Phytochemical and Biological Evaluation of Cassia tora, L. Seedsiosrjce
 
Invitro antioxidant activities of methanolic extract of whole plant of Pedali...
Invitro antioxidant activities of methanolic extract of whole plant of Pedali...Invitro antioxidant activities of methanolic extract of whole plant of Pedali...
Invitro antioxidant activities of methanolic extract of whole plant of Pedali...SriramNagarajan17
 
Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.
Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.
Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.Sulieman Bahar
 
Arenla Presentation.pptx
Arenla Presentation.pptxArenla Presentation.pptx
Arenla Presentation.pptxSaithanpari
 
Determination of foreign matter, heavy metals, pesticide residues, photo toxi...
Determination of foreign matter, heavy metals, pesticide residues, photo toxi...Determination of foreign matter, heavy metals, pesticide residues, photo toxi...
Determination of foreign matter, heavy metals, pesticide residues, photo toxi...Selim Akhtar
 
Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...
Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...
Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...pharmaindexing
 
seminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptxseminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptxSamuelAgboola11
 
seminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptxseminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptxSamuelAgboola11
 
Recent Pre and Post emergence herbicides molecules for field crops with mode ...
Recent Pre and Post emergence herbicides molecules for field crops with mode ...Recent Pre and Post emergence herbicides molecules for field crops with mode ...
Recent Pre and Post emergence herbicides molecules for field crops with mode ...MilindKhedekar2
 
Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...
Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...
Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...inventionjournals
 
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...aruna886550
 
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...aruna886550
 
Improving the Production of Organically Grown Vegetables
Improving the Production of Organically Grown Vegetables Improving the Production of Organically Grown Vegetables
Improving the Production of Organically Grown Vegetables Bureau of Agricultural Research
 
GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...
GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...
GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...Premier Publishers
 
Characteristics of immobilized bacterial D-hydantoinase on alginate
Characteristics of immobilized bacterial D-hydantoinase on alginateCharacteristics of immobilized bacterial D-hydantoinase on alginate
Characteristics of immobilized bacterial D-hydantoinase on alginateAhmed Shawky
 

Similar to PPT-2 MODIFIED(1) (20)

comparsion of anti-inflammatory activity of bauhina variegata
comparsion of anti-inflammatory activity of bauhina variegatacomparsion of anti-inflammatory activity of bauhina variegata
comparsion of anti-inflammatory activity of bauhina variegata
 
tooba shafi presentation.pptx
tooba shafi presentation.pptxtooba shafi presentation.pptx
tooba shafi presentation.pptx
 
Sekar_Powerpoint Presentation UKM
Sekar_Powerpoint Presentation UKMSekar_Powerpoint Presentation UKM
Sekar_Powerpoint Presentation UKM
 
nilab gul new presentation.pptx
nilab gul new presentation.pptxnilab gul new presentation.pptx
nilab gul new presentation.pptx
 
Flash chromatography guided fractionation and antibacterial activity studies ...
Flash chromatography guided fractionation and antibacterial activity studies ...Flash chromatography guided fractionation and antibacterial activity studies ...
Flash chromatography guided fractionation and antibacterial activity studies ...
 
Phytochemical and Biological Evaluation of Cassia tora, L. Seeds
Phytochemical and Biological Evaluation of Cassia tora, L. SeedsPhytochemical and Biological Evaluation of Cassia tora, L. Seeds
Phytochemical and Biological Evaluation of Cassia tora, L. Seeds
 
Invitro antioxidant activities of methanolic extract of whole plant of Pedali...
Invitro antioxidant activities of methanolic extract of whole plant of Pedali...Invitro antioxidant activities of methanolic extract of whole plant of Pedali...
Invitro antioxidant activities of methanolic extract of whole plant of Pedali...
 
Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.
Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.
Isolation and Identification of Flavonoids from leaves of BauhiniarufescensLam.
 
Arenla Presentation.pptx
Arenla Presentation.pptxArenla Presentation.pptx
Arenla Presentation.pptx
 
Determination of foreign matter, heavy metals, pesticide residues, photo toxi...
Determination of foreign matter, heavy metals, pesticide residues, photo toxi...Determination of foreign matter, heavy metals, pesticide residues, photo toxi...
Determination of foreign matter, heavy metals, pesticide residues, photo toxi...
 
Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...
Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...
Phytochemical screening and antiemetic activity of Lepidagatis cristata root ...
 
seminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptxseminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptx
 
seminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptxseminar.2016.Ph.D .4.pptx
seminar.2016.Ph.D .4.pptx
 
Recent Pre and Post emergence herbicides molecules for field crops with mode ...
Recent Pre and Post emergence herbicides molecules for field crops with mode ...Recent Pre and Post emergence herbicides molecules for field crops with mode ...
Recent Pre and Post emergence herbicides molecules for field crops with mode ...
 
Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...
Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...
Bioassay Guided Fractionation and α-Amylase Inhibitory Activity of Lupeol fro...
 
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
 
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
determinationofforeignmatterheavymetalspesticideresiduesphototoxinandmicrobia...
 
Improving the Production of Organically Grown Vegetables
Improving the Production of Organically Grown Vegetables Improving the Production of Organically Grown Vegetables
Improving the Production of Organically Grown Vegetables
 
GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...
GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...
GC-MS Analysis of Ethanolic Extract of Alternanthera Philoxeroides and Altern...
 
Characteristics of immobilized bacterial D-hydantoinase on alginate
Characteristics of immobilized bacterial D-hydantoinase on alginateCharacteristics of immobilized bacterial D-hydantoinase on alginate
Characteristics of immobilized bacterial D-hydantoinase on alginate
 

PPT-2 MODIFIED(1)

  • 1. Presented By- Ruchi Saharan S.Y M.Pharm( Pharmacognosy),GCP Department of Phytochemistry NRPL Isolation & characterisation of Phytoconstituents from Withania somnifera Root
  • 2. Introduction • Withania somnifera has been an important herb in the ayurvedic & indigenous medicinal system for centuries in India.[1] • It is described as an herbal tonic & health food in Vedas and considered as ‘Indian Ginseng’ in traditional Indian system of medicine.[2] • Medicinally important plant known for variety of pharmacologically important withanolides & their glycosides. • Ashwagandha plant is especially attractive for studying the enzymes involved in steriodal transformation like glycosylation because it is a rich source for variety of glycosylated steroidal lactones called withanosides present in roots & leaves.[3] • Withanosides mainly comprises of withanolides with one or more glucose units attached to C- 3 or C-27 position. 2
  • 3. Plant profile[4] Withania somnifera Botanical Name: Withania somnifera (L) Dunal Family : Solanaceae Synonyms(s) : Physalis flexuosa L 3
  • 4. Taxonomical classification[4] Kingdom : Plantae Division : Angiosperma Class : Dicotyledoneae Order :Tubiflorae Family : Solanaceae Genus :Withania 4
  • 5. Macroscopic[5],[6] • The sout fleshy roots when dry are cylindrical, gradually tapering down, straight, unbranched, 10-17.5cm long & 6-12mm in diameter. • The main roots bear fibre-like secondary roots. • The outer surface of the roots is brownish white and interior in creamy white when broken. • They have a short and uneven fracture, a strong odour and mucilaginous bitter & acrid taste. 5
  • 6. Microscopic [5],[6] • The young roots has a single layered epidermis followed by parenchymatous cortex of 4-5 layers of cells, the endodermis being conspicuous by the presence of casparian stipes. • The cork cambium arises in the outermost layer of the cortex. • The endodermis persists even after the secondary growth has been taken place. 6
  • 7. Geographical Distribution[7] • Withania somnifera is widely distributed around the world from Southern Mediterranean regions to the canary island and from south to East Africa, from Palestine to north India. • India the plant can be seen growing wild in the North Western regions extending to the mountains regions of Punjab, Himachal Pradesh and Jammu up to an altitude of 1,500m. 7
  • 8. Chemical constituents [8,9,10] 8 SL.No Category Phytoconstituents 1 Alkaloids Withanine,Withaninine, Somniferine,Tropeltigloate, Somniferinine, somninine,Visamine,Withasomine. 2 Salts Cuscohygrine,Anahygrine,Tropine,Pseudotropine,Anaferine. 3 Steriodal lactones Withaferin –A,Withanone,WS-1, Withanolide-A,B,E,F,G,H,I,J,K,L,M, 12- deoxy Withastramonolide, Withanoside IV, Withanoside V. 4 N- containing lactones Withanol, Somnisol,Somnitol. 5 Steroids Cholesterol,β-sitosterol, stigmasterol,Diosgenin,stigmastadien,sitoinosidesVII, sitoinosides VIII, Sitoinosides IX, sitoinosides X. 6 Flavonoids Kaempferol,Quercetin.
  • 9. WITHANOLIDES [8] • These are group of naturally occuring steroids built on an ergostane skeleton in which C-22 & C-26 are appropriably oxidised to form a α- lactone ring, occuring almost exclusively in the solanaceae family. • Two new and seven known withanolides along with β-sitosterol, stigmasterol, β- sitosterol glucoside, stigmasterol glucoside, α + β glucose were isolated from the roots of Withania somnifera. • Among the known compounds, Viscosa lactone B, stigmasterol, stigmasterol glucoside and α + β glucose are being reported from the roots of W. somnifera for the first time. • One of the new compounds contained the rare 16β-acetoxy-17(20)-ene the other contained unusual 6α-hydroxy-5,7α-epoxy functional groups in the withasteroid skeleton. 9
  • 10. Structures O CH3 OH CH3 H3C OH CH3 O O WITHAFERIN A O O CH3 CH3 CH3 OH H3C OH O OH WITHANOLIDE A CH3 OH CH3 CH3 OH O H3C O O WITHANOLIDE B HO O O H H O O OH H H H 12-deoxy WITHASTRAMONOLIDE 10
  • 12. Traditional and medicinal uses[11] Roots of the plant withania somnifera reportedly exhibits: • Anti-inflammatory • Antitumor • Antistress • Antioxidant • Immunomodulatory • Haematopoietic • Aphrodisiac • Dyspepsia • Sedative Carminative • Diuretic • Bactericide 12
  • 13. Objectives • To isolate Root specific marker which are absent in leaves /aerial part. • Isolation of Withanolide-B & other Withanolides from enriched fractions. • Isolation of new marker apart from our regular compounds. • Publication on Root specific markers & others. 13
  • 14. Previous work done • Yogendra et.al-PLT-129 • The compound isolated was a derivative of withanolide which is having conjugated diene ring system. The proposed structure was • The compound isolated is specific to roots only (Confirmed by HPLC). 14 O O O H3C CH3 CH3 CH3 CH3 OH
  • 15. Partitioning of Withania somnifera methanolic extract – Pilot scale 15 Present Work
  • 16. 16 Withania somnifera methanolic extract 3Kg Ethyl acetate layer 35.33% (1060g) Butanol layer 37.0% (1110g) Water layer 20.67% (620.5g) Mixed layer 2.0% (60.1g) Total quantity= 2.85Kg HPLC analysis was carried out on all the above fractions Partition with 45L of solvents
  • 18. 18
  • 19. Partition Quantification Sl. No. Sample Withanoside IV Withanoside V Withaferin A Withastra monolide Withanolide A Withanolide B Total Assay of WSR-03 1 Initial ME ext 0.42 0.45 0.26 0.26 0.41 0.12 2.42 0.016 2 EA layer 0.43 0.31 3.04 3.04 2.94 0.86 15.23 0.154 3 Butanol layer 4.69 3.73 1.19 1.19 1.80 0.36 15.62 0.025 4 Water layer 0.41 0.68 0.17 0.17 0.27 0.02 2.05 ND 19
  • 20. Column chromatography on Ethyl acetate fraction... Column -1 1Kg of Ethyl acetate fraction + 2Kg of silica (120- 200) mixed adsorbed dried it. Column charged with silica (60-120) 3Kg(1:3) Using wet packing. sample is packed & 100% PE was elulated to deffat drug Subsequently the mobile phase was (PE : EA) in the ratio of 90 : 10, 80 :20, 70 : 30, 60 : 40....... 20
  • 21. F1 80:20 P/E F2(1) 70:30 P/E F2(2) 70:30 P/E F3 60:40 P/E F4 50:50 P/E F5 40:60 P/E F6 30:70 P/E F7 20:80 P/E F8 10:90 P/E F9 100 EA F10 90:10 E/M F11 80:20 E/M F 12 60:40 E/M F13 40:60 E/M F 14 20:80 E/M F15 100 M F16 50:50 M/H2O 67.5 g 49.5g 72.0 g 43.0 g 29.5 g 25.5 g 30.0 g 49.5 g 55.0 g 54.5 g 56.0 g 78.0 g 135.0 g 44.5 g 79.5 g 24.5 g 14.0 g 1 Kg of Withania Ethyl acetate partition layer • P/E= PE:EtOAc • E/M = EtOAc: MeOH 5L of solvent is run 21 Total quantity obtained= 907g HPLC analysis was carried out for the above fractions
  • 23. 23
  • 25. Quantification Result-Column 1 Sample Wt. Withanoside IV Withanoside V Withaferin A Withastramonolide Withanolide A Withanolide B Total WSR-03 WSR-01 EA layer 1060g 0.21 0.31 6.88 1.83 2.08 0.63 11.94 0.14 0.24 F-5 29.5g 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.16 ND F-6 25.5g 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.63 0.19 F-7 30.0g 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.17 0.53 F-8 49.5g 0.37 0.00 1.71 0.13 2.54 1.16 5.92 0.51 0.79 F-9 55.0g 0.44 0.06 3.29 0.24 2.32 1.14 7.49 0.43 1.01 F-10 54.5g 0.63 0.17 10.58 1.20 7.05 2.17 21.80 0.17 0.96 F-11 56.0g ND ND 18.65 4.13 4.69 1.33 28.81 0.08 0.43 F-12 78.0g 0.39 ND 17.79 4.77 4.19 1.35 28.49 0.10 0.42 F-13 135.0g ND ND 13.54 4.72 2.69 0.43 21.38 0.00 0.00 F-14 44.5g 2.21 3.78 2.71 2.23 2.00 0.42 13.35 0.00 0.00 F-15 79.5g 2.70 2.62 1.94 1.82 1.96 0.46 11.50 0.00 0.00 F-16 24.5g 1.43 1.10 1.08 1.36 1.85 0.47 7.30 0.00 0.00 F-17 14.0g 1.19 1.00 3.15 0.91 0.68 0.12 7.05 0.00 0.00 25 Selected for COLUMN -2
  • 26. Future Plan of work • Fractions-10,11,12,13 from Column -1 were selected for next Silica column to isolate Withanolide B & to generate enriched fractions for WSR-03, 01 & other withanolides. 26
  • 27. Column chromarography-2 27 300g of fractions -10,11,12,13 of Column-1 C2F1 100%PE C2F2 90:10 PE:EA C2F3 80:20 PE:EA C2F4 70:30 PE:EA C2F5 60:40 PE:EA C2F6 50:50 PE:EA C2F7 40:60 PE:EA C2F8 30:70 PE:EA C2F9 20:80 PE:EA C2F10 10:90 PE:EA C2F11 100%EA C2F12 90:10 EA:MeOH C2F13 70:30 EA:MeOH C2F14 50:50 EA:MeOH 100% MeOH 0.3g - 2.5g 3.3g 9.6g 6.3g 10.3g 22.2g 14.2g 14.2g 57.0g 113.0g 40.0g 7.4g 1.8g Column-3 Column-4 Total Quantity Obtained=292.5g Column-5 Targeted WSR-03
  • 28. HPLC Analysis (WSR-03,01 Quantification) 28 WSR 03 2.04/25 RT 28.17 ASSAY ASSAY sample Weight WSR 03 WSR 01 Control 0.08 0.36 F4 3.3g 0 0.00 F5 9.6g 1.34 0.00 F6 6.3g 1.22 0.00 F7 10.3g 0.27 1.41 F8 22.2g 0.00 3.29 F9 14.2g 0.15 0.80 F10 14.2g 0.05 0.51 F11 57.0g 0.01 0.09 F12 113.0g 0.00 0.05 COLUMN-3 COLUMN-4
  • 29. Withanolide Quantification 29 Batch No Weight Withanoside V Withaferin A Withastramonolid e Withanolide A Withanolide B Control 17.03 5.59 3.92 1.13 F4 3.3g 0.00 0.00 0.00 0.00 0.00 F5 9.6g 0.00 0.00 0.00 0.00 0.00 F6 6.3g 0.00 0.00 0.00 1.56 0.00 F7 0.3g 0.00 0.00 0.00 1.39 1.98 F8 22.2g 0.00 0.00 0.00 1.69 3.60 F9 14.2g 0.00 0.00 0.00 11.45 2.12 F10 14.2g 0.00 5.55 0.00 10.03 2.68 F11 57.0g 0.00 23.24 8.01 4.64 1.12 F12 113.0g 0.00 17.57 5.21 2.53 0.44 F13 40.0g 0.00 4.21 2.45 1.87 0.18 F14 7.4g 1.88 1.70 1.11 0.70 0.08 F15 1.8g 1.04 0.37 0.30 0.11 COLUMN-3 COLUMN-4
  • 31. 31
  • 33. Column Chromatography-3 33 C3F6 C3F7(1) PPT C3F7(2) C3F7(3) C3F7(3) MLR C3F7(1),(2) MLR C3F8 C3F9 C3F10 C3F11 C3F11- MLR C3F12 C3F13,14, 15,16 EA:CHCl3 10:90 EA:CHCl3 20:80 EA:CHCl3 20:80 EA:CHCl3 20:80 EA:CHCl3 20:80 EA:CHCl3 20:80 EA:CHCl 3 30:70 EA:CHCl3 40:60 EA:CHCl3 30:70 EA 100% EA 100% MeOH:EA 10:90 MeOH:EA 25%,50% 100%MeOH,50 % H2O 0.3g paste powder 87.0mg Light Green powder 147.47mg light Green powder 0.2g paste 2.1g paste 0.6g paste 3.6g paste 4.3g paste 683.0mg White powder 2.9g Brown paste 4.8g paste 2.4g Brown paste C2F8 Qty charged (21g) - Wet-packing Total quantity obtained= 19.5gm Isolated Withanolide –B New peak RT-19.954 WSR-01 Enriched + Withanolide-B
  • 34. 34 WSR 03 2.04/25 RT 28.13 ASSAY ASSAY sample Weight WSR 03 WSR 01 C-3 Control - 0.00 2.96 C3-F6 0.3g C3-F7(1&2)MLR 2.1g 0 14.01 C3-F7(2) 87.0mg 0 6.97 C3-F7(3) 147.47g 0 3.61 C3-F7(3)MLR 0.2g 0.48 C3F8 0.6g 1.83 0.60 C3F9 3.6g 0.51 C3F10 4.3g 1.23 0.20 C3F11 683.0mg 0.71 C3F11MLR 2.9g 0.66 C3F12 4.8g 0.20 0.19 C3F13,14,15,16 MIX 2.4g 0.13 WSR-03,01 Quantification WSR-01 Enriched fractions WSR-03 Enriched fractions
  • 35. Withanolide Quantification 35 Sr.no Batch No Weight Withanolide A Withanolide B - 1 C-3 Control 1.65 3.06 2 C3-F6 0.3g 3.90 1.19 3 C3-F7(1&2)MLR 2.1g 8.71 4 C3-F7(2) 87.0mg 61.31 5 C3-F7(3) 147.47g 56.67 6 C3-F7(3)MLR 0.2g 0.51 4.83 7 C3F8 0.6g 0.68 8 C3F9 3.6g 3.53 9 C3F10 4.3g 0.19 0.00 10 C3F11 683.0mg 11 C3F11MLR 2.9g 12 C3F12 4.8g 13 C3F13,14,15,16 MIX 2.4g -
  • 36. Column Chromatography-4 36 C4F6 (2),(3) C4F7 (1),(2) PPT C4F7 (1),(2) MLR C4F8 C4F8 MLR C4F9 (1),(2) C4F9 MLR C4F10 PPT C4F10 MLR C4F10 (2) C4F11 (1) C4F11 C4F12 PPT C4F12 MLR C4F13 C4F 14,15 MIX EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 EA:CHCl3 100% EA 100&EA MeOH: EA MeOH: EA MeOH: EA MeOH: EA 25,50,100% MeOH, 50%H20 1.4g paste 0.9g paste 439.80 mg powder 4.6g paste 1.28g powder 2.0g Green powder 3.24g powder 3.6g paste 4.2g powder 0.3g Greenish powder 9.8g paste 342mg powder 1.7g paste 3.4g paste 418.0mg Brown powder Withanolide –B Islolated C2F9 & C2F10 Qty charged- 27g (wet-packing) Total quantity obtained= 25.5g Withanolide –A Enriched fraction Withanolide-A & Withastramonolide Enriched fractionWithanolide-A & B Enriched fraction Withanoside IV Enriched New peak RT- 23.642 Withaferin-A Enriched
  • 37. • From fractions C3F7(1) & C4F7 (1,2) 190.0mg Withanolide –B isolated (> 95%). 37 Combined
  • 38. Withanolide Quantification 38 Sr.no Batch No Weight Withanoside IV Withanoside V Withaferin A Withastramonoli de Withanolide A Withanolide B 1 C-4 Control - 1.91 0.62 3.46 6.00 8.28 1.98 2 C4F6(2&3) 1.4g 0.00 0.00 0.00 0.00 0.23 0.00 3 C4F7(1&2MLR) 0.9g 0.00 0.00 0.00 0.00 0.00 4.53 4 C4F8 439.80 0.00 0.00 0.00 0.00 13.80 24.69 5 C4F8MLR 4.6g 0.00 0.00 0.00 0.00 2.50 6.11 6 C4F9(1&2) 1.28g 0.00 0.00 0.00 0.00 49.64 8.47 7 C4F9MLR 2.0g 0.00 0.00 0.00 3.84 18.91 5.61 8 C4F10(2) 3.24g 7.53 0.00 0.00 11.88 9.00 0.00 9 C4F10MLR 3.6g 34.37 0.00 0.00 3.07 0.59 0.00 10 C4F10PPT 4.2g 0.00 0.00 0.00 26.12 34.75 0.00 11 C4F11(1) 0.3g 0.00 2.66 7.99 4.39 0.00 0.00 12 C4F11 9.8g 1.80 5.21 0.00 0.00 0.00 13 C4F12MLR 342.0mg 0.00 0.00 0.00 0.00 0.00 14 C4F12PPT 1.7g 0.00 0.00 0.00 0.00 15 C4F14&15 MIX 418.0mg 0.00 0.00 0.00 0.00 0.00 0.00
  • 39. WSR-03 Quantification 39 Sr.No sample weight WSR 03 WSR 01 1 C-4 Control - 0.07 0.53 2 C4F6(2&3) 1.4g 0 3 C4F7(1&2MLR) 0.9g 1.6 0.00 4 C4F8 439.80 0.29 0.78 5 C4F8MLR 4.6g 1.46 4.76 6 C4F9(1&2) 1.28g 0.14 0.29 7 C4F9MLR 2.0g 0.87 4.22 8 C4F10(2) 3.24g 9 C4F10MLR 3.6g 10 C4F10PPT 4.2g 11 C4F11(1) 0.3g 12 C4F11 9.8g 13 C4F12MLR 342.0mg 14 C4F12PPT 1.7g 15 C4F14&15 MIX 418.0mg
  • 40. Column Chromatography-6 40 (C6F1-C6F5) PE:CHCl3 75:25 50:50 25:75& 100 % CHCl3 C6F6 (1) C6F6 (2) C6F6 (3) C6F7 (1) C6F7 (2) C6F8(1) C6F8 (2) C6F8 (3) C6F9 (1) C6F9 (2) C6F10 (1) C6F11 EA:CHCl3 20:80 EA:CHCl3 20:80 EA:CHCl3 20:80 EA:CHCl3 40:60 EA:CHCl3 40:60 EA:CHCl3 60:40 EA:CHCl3 60:40 EA:CHCl3 60:40 EA:CHCl3 80:20 EA:CHCl3 80:20 100% EA MeOH: EA 20:80 & 100% MeOH 9.0g powder 9.0g powder 3.5g powder 5.2g powder 10.0g powder 7.6g powder 4.0g powder 2.3g powder 2.6g powder 1.9g powder 1.3g powder 1.9g Brown powder C2F11 Qty charged: 56g (wet-packing) Total quantity obtained= 54.3g New peak RT-12.639 New peak RT-15.939 New peak RT-17.494 Column-7 Target –Peak RT-15.9 Withaferin –A Side peak
  • 41. Withanolide Quantification (C-6) 41 Sr.No Batch No Weight Withaferin A Withastramonolide Withanolide A Withanolide B 1 C6-Control-13 - 18.15 6.71 4.23 0.96 2 C6F6-1 9.0g 16.50 9.17 9.18 4.07 3 C6F6-2 9.0g 17.29 7.66 6.26 1.83 4 C6F6-3 3.5g 17.30 7.42 5.35 0.35 5 C6F7-1 5.2g 18.28 6.44 3.57 0.00 6 C6F7-2 10.0g 17.69 5.94 2.38 0.00 7 C6F8-1 7.6g 22.40 5.68 0.42 0.00 8 C6F8-2 4.0g 15.15 4.66 0.00 0.00 9 C6F8-3 2.3g 9.83 2.59 0.00 0.00 10 C6F9-1 2.6g 6.67 1.87 0.00 0.00 11 C6F9-2 1.9g 9.35 1.09 0.00 0.00 12 C6F10-1 1.3g 3.36 0.55 0.00 0.00 13 C6F11-1 1.9g 4.69 0.00 0.00 0.00 C-7
  • 43. OVERLAY OF PEAK (RT-17) 43
  • 44. Column Chromatography-7 44 C7F1 C7F2 C75F3 C7F4(1) C7F5(1) C7F5(2) C7F5(3) C7F6(1) C7F6(2) C7F6(3) C7F6(4) C7F6(5) C7F7(1) 100% PE 5% Ac: PE 10% Ac: PE 15% Ac: PE 20% Ac: PE 20% Ac: PE 20% Ac: PE 25% Ac: PE 25% Ac: PE 25% Ac: PE 25% Ac: PE 25% Ac: PE 30% Ac: PE - - - 11.0mg powder 2.7g powder 1.8g powder 0.8g powder 20.0mg powder 5.0mg powder 3.0mg powder 2.0mg powder 3.0mg powder 5.0mg powder C6F8(1) Qty:7g charged ( wet-packing) Ac : Acetone PE: Petroleum Ether Total Qty obtained= 5.3g Enriched with peak RT-15 Isolated Withaferin-A (1.0g) By crystaliazation
  • 46. Quantification 46 Sr.No Batch No Weight Withanoside -IV Withanoside -V Withaferin - A Withastramonolide 1 C7 CONTROL - 0 0 0.56 0.53 2 C7F4 11mg 0 0 41.29 24.51 3 C7F5(1) 2.7g 0 0 12.83 8.32 4 C7F5(2) 1.8g 0 0 68.25 2.179 5 C7F5(3) 0.8g 0 0 46.65 2.61 Enriched with peak RT-15.15
  • 47. Quantification (Peak RT-14.8 & 15.15) 47 RT 14.8 weight Assay C7-Control - 23.29 C7F5(1) C7F5(2) 1.8g 5.58 C7F5(3) 0.8g 24.75 RT 15.15 weight Assay C7-Control - 10.43 C7F5(1) C7F5(2) 1.8g 4.48 C7F5(3) 0.8g 7.75
  • 48. Column Chromatography- 5 C5F1 C5F2 C5F3 C5F4(1) C5F4(2) C5F4(3) C5F4(4) C5F5(1) C5F5(2) C5F6 PPT C5F6 MLR C5F7 (1) C5F8 100% PE 50% CHCl3 : PE 75% CHCl3 : PE 3% EA:CHCl3 3% EA:CHCl3 3% EA:CHCl3 3% EA:CHCl3 10% EA:CHCl3 10% EA:CHCl3 15% EA:CHCl3 15% EACHCl3 20% EACHCl3 100% MeOH 48 C2F6 Qty charged-6g (wet-packing) Enriched with WSR-03
  • 50. WSR-03 Quantification 50 Sr.No Sample Assay WSR 03 1 Control 1.05 2 C5F4 (2) 4.63 3 C5F4( 3) 7.29
  • 51. Column Chromatography- 8 (HP20 Diaion) 51 C1F7 Qty charged-30g C8F4 C8F5 C8F6 C8F7 C8F8 C8F9 C8F10 C8F11 C8F12 C8F13 C8F14 C8F15 10+20% Acetone: H2O 30% Acetone: H2O 35% Acetone: H2O 35+40% Acetone: H2O 40% Acetone: H2O (MLR)-1 40% Acetone: H2O (MLR)-2 45% Acetone: H2O (MLR)-1 45% Acetone: H2O (MLR)-2 50% Acetone: H2O 60% Acetone: H2O 80% Acetone: H2O 100% Acetone - - - - - - 2.0g 1.0g 1.5g 1.5g 15.0g 7.5.0g Enriched with WSR-03,01
  • 52. 52 Sr.no sample Wt Assay WSR 03 Assay WSR 01 1 Control - 1.19 0.54 2 F10 2.0g 2.09 3.16 3 F11 1.0g 5.17 2.09 4 F12 1.5g 3.90 0.27 5 F13 0.17 0.00 Quantification Result
  • 53. 53 Column Chromatography-9 (HP 20 Diaion) C9F1 C9F2 C9F3 C9F4 C9F5 C9F6 C9F7 C9F8 100% H2 O 10% Acetone: H2 O 20% Acetone: H2 O 30% Acetone: H2 O 40% Acetone: H2 O 60% Acetone: H2 O 80% Acetone: H2 O 100% Acetone 0.2 0.1g 0.2g 0.2g 2.1g 1.2g 6.1g 9.0g C1F6 Qty charged-20.0g Total Quantity obtained= 18.2 g
  • 54. 54 C10F3 C 10F4 C10F5 (PPT) C10F6 (MLR) C10F6 (PPT) C10F6 (MLR) C10F7 C10F8 30% Acetone: H2 O 40% Acetone: H2 O 50% Acetone: H2 O 50% Acetone: H2 O 60% Acetone: H2 O 60% Acetone: H2 O 80% Acetone: H2 O 100% Acetone 0.2g 10.0g 7.0g 5.0g 0.5g 5.0g 25.0g 20.0g Column Chromatography-10 (HP 20 Diaion) C1F6 Qty charged-80.0g Total Quantity obtained= 72.7g
  • 55. 55 C11F2 C11F3 C11F4 C11F5 C11F6 C11F7 C11F8 C11F9 C11F10 C11F11 C11F12 10% EA:CHCl3 20% EA:CHCl3 30% EA:CHCl3 40% EA:CHCl3 60% EA:CHCl3 80% EA:CHCl3 100% EA 10% MeOH:EA 20% MeOH:EA 40% MeOH:EA 70% MeOH:EA + 100% MeOH 85.92mg 164.6mg 1.7g 2.9g 310.6mg 922.5mg 1.7g 13.5g 24.7 20.0g 2.2g Column chromatography-11 C1F14 Qty charged-75.0g (Wet packing) Isolated Withanolide-B Isolated Withanolide-A New peak RT-17.2 Withastramonolide + Withaferin –A enriched Column-12
  • 58. 58
  • 59. 59
  • 60. 60
  • 61. 61
  • 63. References 1. Indian Herbal Pharmacopoeia A Joint Publication of Regional Research institute (Jammu Tawai) and Indian Drug Manufacturer’s Association (Mumbai); 1999. 2. Owais M, Sharad KS, Shehbaz A, Saleemuddin M. Antibacterial efficacy of withania somnifera an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine. 2005;12:229- 235. 3. Bhaskara RM, Lokendra KS, Pankaj C, Rajender SS, Rakesh T. Purification & characterization of a novel glucosyltransferase specific to 27- hydroxyl steriodal lactose from withania somnifera and its role in stress responses Biochimica Biophysica Acta.2007; 1774: 1199-1207. 4. Withania somnifera Master Document; Natural Remedies Private Ltd.Bengaluru. 5. The Unani Pharmacopoeia of India. Part I, Vol. I, Depat. of AYUSH, Ministry of Health & Family Welfare, Govt. of India, New Delhi (2007) 7-8. 6. Standardisation of Single Drugs of Unani Medicine. Part III, 1st ed. Central Council for Research in Unani Medicine (CCRUM), New Delhi (2007) 9-14. 7. Shah CS and Qadri JS. Textbook of Pharmacognosy. 9th ed. BS Shah Prakashan, New Delhi (1993). 8. Singh S, Kumar S, withania somnifera: The Indian Ginseng, Ashwagandha. Central Institute of Medical an Aromatic Plants, Lucknow, India; 1998 63
  • 64. 9. Wilk, S Orlowski, M wilk, Pearce. Novel in vitro and in vivo inhibitors of Prolyendo peptidase. Journal of Neurochemistry life sci. 1983; 33: 2149- 2157. 10. Steroids-Chemical constituents of Withania somnifera Dunal through TLC & HPLC. Monika christian et.al. IRJP.ISSN 2321-2845,2321,3299. 11. Mark E , Allan W, Nicholas, John PR. High presssure liquid chromatography of derivatives & microbial metabolites of withaferin- A. J . Chrom. 1977; 137; 465-467. 12. Traditional And Medicinal Uses of Withania Somnifera. M. Umadevi1 et.al. The Pharma Innovation . 2012, vol.1 No.9 : 102-110 64
  • 65. 65